Task: Answer the multiple choice question.
Query: Which drug exhibits a -19.126% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CCN(C(=O)Cc1c(C(=O)O)n(CC)c2ccccc12)c1ccccc1C
b.) CCOc1ccc(NS(=O)(=O)c2ccc3ncsc3c2)cc1
c.) CC(=O)C1=C(C)N(CC2CC2)C(=O)N[C@H]1c1ccc(Br)cc1
d.) Cc1cc(C)nc(N2CCCC(C(=O)NCc3ccccc3)C2)n1
e.) CCCn1c(NC(=O)CN2C(=O)NC3(CCCCC3)C2=O)nc2ccccc21
Answer: e. CCCn1c(NC(=O)CN2C(=O)NC3(CCCCC3)C2=O)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(NC(=O)CN2C(=O)NC3(CCCCC3)C2=O)nc2ccccc21
CCCn1c(NC(=O)CN2C(=O)NC3(CCCCC3)C2=O)nc2ccccc21
2-(2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl)-N-(1-propylbenzimidazol-2-yl)acetamide